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Aurora-A controls pre-replicative complex
assembly and DNA replication by
stabilizing geminin in mitosis
Takaaki Tsunematsu1, Yoshihiro Takihara2, Naozumi Ishimaru3, Michele Pagano4,5,
Takashi Takata1 & Yasusei Kudo1,3
Geminin, an essential factor for DNA replication, directly binds to the licensing factor Cdt1
and inhibits pre-replicative complex formation to prevent re-replication. In G1, geminin levels
are controlled by the anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase
complex, which targets geminin for proteasomal degradation to allow pre-replicative complex
formation. Conversely, from S to G2, geminin is stabilized due to APC/C ubiquitin ligase
complex inhibition, ensuring the inhibition of pre-replicative complex formation. However,
mitotic regulation of geminin has hitherto not been described. Here we show that Aurora-A
phosphorylates geminin on Thr25 during M phase, and this event induces geminin stabili-
zation by preventing its APC/C ubiquitin ligase complex-mediated degradation during
mitosis. In turn, stabilized geminin inhibits SCFSkp2-mediated degradation of Cdt1 to ensure
pre-replicative complex formation in the ensuing S phase. The Aurora-A–geminin–Cdt1 axis
therefore represents a critical regulator of proper DNA replication.
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I
n eukaryotes, DNA replication is restricted to occur only once
per cell cycle. Licensing is mediated by the assembly of the
pre-replicative complex (pre-RC) on replication origins. The
assembly of the essential pre-RC at these origins can only occur
between late mitosis and early G1 when cyclin-dependent kinase
(CDK) activity is low and anaphase-promoting complex/
cyclosome ubiquitin ligase complex (APC/C) activity is high.
The pre-RC is composed of the origin recognition complex
(ORC), Cdc6, Cdt1 and the mini-chromosome maintenance
(MCM) proteins1. During late M and early G1, Cdc6 and Cdt1
are loaded onto replication origins in an ORC-dependent manner
and subsequently recruit MCM proteins to the origins. Once the
pre-RC are assembled, origins are licensed for replication in the
subsequent S phase and are ready to ﬁre. Geminin, a known
repressor of re-replication, directly binds to Cdt1 and inhibits its
function2. Furthermore, geminin controls the basal level of
Cdt1 and induces its accumulation during mitosis by inhibiting
its ubiquitin-dependent proteolysis2. Thereby, the depletion of
geminin during mitosis causes the destabilization of Cdt1
and subsequently prevents MCM loading in the subsequent G1
(ref. 3). Thus, it is proposed that geminin has both negative and
positive roles in pre-RC formation, indicating that protein level of
geminin must be appropriately and strictly controlled to ensure
proper DNA replication.
The protein level of geminin is regulated by the ubiquitin-
proteasome system; geminin is degraded at the exit of mitosis by
the APC/C complex in Xenopus egg extract4, whereas it is a target
of the APC/CCdh1 ubiquitin ligase complex in mammalian
cells5,6. The APC/C activity is dependent on its co-activators,
Cdc20 and Cdh1, which associate with APC/C during speciﬁc
periods in the mammalian cell cycle7. APC/CCdc20 is active early
in mitosis, and APC/CCdh1 has an essential role from late M to
the G1/S transition7. Cdh1 can only activate APC/C once APC/
CCdc20 has decreased the CDK1 activity by initiating cyclin
destruction, when Cdh1 has been dephosphorylated by protein
phosphatases in late M (ref. 7). DNA replication depends on
the APC/C-mediated degradation of geminin, which releases
the inhibition of Cdt1 incorporation into pre-RCs and permits
the proper assembly of these complex components2,8. Origin
ﬁring can only occur after the APC/C is inactivated and CDKs
become active. To strictly inhibit the assembly of pre-RC during
S–G2 phase, APC/C is inactivated by several mechanisms:
binding to its inhibitor Emi1, CDK-mediated phosphorylation
of Cdh1 (which blocks its ability to activate APC/C), and
degradation of both Cdh1 (ref. 9) and its major UBC, namely
UbcH10 (ref. 10).
In this study, we found that Aurora-A phosphorylates geminin
to protect it from APC/C during mitosis. In turn, Aurora-
A-mediated stabilization of geminin inhibits SCFSkp2-mediated
degradation of Cdt1 to ensure pre-RC formation in the ensuing
S phase.
Results
Phosphorylation of geminin prevents its degradation. Geminin
protein levels oscillate during the cell cycle, that is, accumulating
in S and disappearing in early G1 (Supplementary Fig. S1a). The
half-life of geminin in mitosis (mitotic geminin) was elongated
compared with that of either asynchronous or G1-synchronized
cells (Supplementary Fig. S1b,c), and treatment with the protea-
some inhibitor MG132 resulted in geminin protein accumulation
in G1 (Supplementary Fig. S1d). Geminin is known to be ubi-
quitylated via APC/C in G1 phase4. Recent analyses at the single-
cell level by immunocytochemistry have shown the timing of
geminin degradation in mitosis, which takes place following
cyclin B degradation, in late anaphase11. We conﬁrmed that the
depletion of Cdh1 stabilized geminin protein (Supplementary
Fig. S1e). Emi1 is induced by E2F to inactivate APC/CCdh1 at the
G1/S transition12. At the onset of mitosis, Emi1 is degraded
following the phosphorylation by Plk1 and ubiquitylation by
SCFb-TrCP, and this allows the activation of APC/C13,14. Although
geminin is absent during G1 and accumulates during S, G2 and
M, consistent with the idea that it is an APC/C substrate, geminin
is stable even in mitosis after APC/C is activated. These ﬁndings
led us to hypothesize that geminin may be stabilized during
mitosis by a hitherto unknown pathway.
We ﬁrst noted a band shift of geminin during mitosis by
immunoblotting (Supplementary Fig. S1a). The band shift was
eliminated by l-phosphatase (l-PPase) treatment (Fig. 1a),
suggesting that geminin is phosphorylated during mitosis.
Therefore, we assumed that phosphorylation is important for
geminin stabilization during mitosis. Geminin is a highly
conserved protein and has three conserved putative
phosphorylation serine/threonine sites, Thr25, Ser32 and Ser60,
surrounding the destruction box (D-box) motif that is recognized
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Figure 1 | Geminin is stabilized during mitosis through the blockade
of proteasomal degradation. (a) Noc-arrested HeLa cells were used as
arrested mitotic cells (at mitotic shake-off) (Noc) and adherent cells
after mitotic shake-off (Ad). Synchronized cell extracts were treated with
l-PPase at 30 C for 30min. Cdc25A and phospho-histone H3 (pHH3)
were used as controls for phosphorylated proteins. MW, molecular weight
in kDa. (b) Candidates for conserved phosphorylation sites in geminin.
Geminin phosphorylation sites in Homo sapiens (Thr25, Ser32 and Ser60)
are conserved in other species. D-box indicates an APC/CCdh1-recognition
site designated as a destruction box. (c) HeLa cells were transfected with
either FLAG-tagged wild-type (WT) geminin, gemininT25D, gemininS32D or
gemininS60D. Cells were synchronized by Noc. Cells in M were collected
after 0 h from mitotic shake-off. Cells in G1 were collected in G1 after
Noc release for 4 h. FLAG-tagged geminin, pHH3 and Cul1 expressions
were examined by immunoblotting. MW, molecular weight in kDa.
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by APC/C (Fig. 1b). To identify the phosphorylation site and
further clarify the implication in geminin protein stability, we
generated three phospho-mimicking mutants, gemininT25D,
gemininS32D and gemininS60D, in which serine/threonine was
replaced with aspartic acid. Cells overexpressing either of these
mutants were synchronized in M (noc 0 h) and G1 (noc 4 h).
These mutants were highly expressed in M, but only gemininT25D
was abundant in G1 (Fig. 1c). Interestingly, Thr25 is a component
of the D-box in geminin (Fig. 1b). We also generated a phospho-
defective mutant (T25A) by replacing threonine with alanine. We
examined the stability of these mutant molecules after the release
from nocodazole (Noc) arrest. GemininT25A was already unstable
during M, whereas gemininT25D remained stable during G1
(Fig. 2a). We further conﬁrmed this phenomenon through double
thymidine block release (Supplementary Fig. S2a). In G1 extracts,
in vitro-translated gemininT25A degraded faster than wild-type
geminin, whereas gemininT25D was stable (Fig. 2b). MG132
treatment increased wild-type geminin and gemininT25A, but not
gemininT25D, protein levels (Supplementary Fig. S2b). These
ﬁndings suggest that geminin is phosphorylated on Thr25 during
mitosis and is degraded via APC/CCdh1 in G1 phase after
dephosphorylation. To demonstrate this hypothesis, we examined
the effect of Thr25 phosphorylation on geminin degradation by
APC/CCdh1. Cdh1 depletion increased wild-type geminin and
gemininT25A, but not gemininT25D, protein levels (Supplementary
Fig. S2c). As Emi1 depletion is known to give rise to ectopic
APC/CCdh1 activation5, we attempted to deplete Emi1, resulting
in the reduction of wild-type geminin and gemininT25A, but not
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Figure 2 | Phosphorylation of geminin on Thr25 during mitosis prevents its proteasomal degradation by both APC/CCdh1 and APC/CCdc20. (a) HeLa
cells were transfected with either wild-type (WT) geminin, gemininT25A or gemininT25D, and synchronized in M–G1 by Noc. Cells were collected at 0, 2
and 4 h after mitotic shake-off. FLAG-tagged geminin, phospho-histone H3 (pHH3) and Cul1 expressions were examined by immunoblotting. (b) The half-
life of IVT-myc-tagged geminin proteins (WT, T25A and T25D) were examined by the in vitro degradation assay. Cell extracts were obtained from
synchronized HeLa cells in G1 (5 h after mitotic shake-off). Cell lysates with IVT-myc-tagged geminin protein were incubated for the indicated times. IVT-
myc-tagged geminin protein expression was examined by immunoblotting with an anti-myc antibody. (c) An in vitro ubiquitylation assay was performed
using 35S-labelled IVT-geminin WT, gemininT25A or gemininT25D, and immunopuriﬁed APC/CCdh1 from HeLa cells. 35S-labelled IVT-geminin protein was
incubated for the indicated times at 30 C. The abundance of 35S-labelled IVT-geminin proteins was detected by autoradiography. (d) FLAG-tagged
geminin WT, gemininT25A or gemininT25D, with or without HA-tagged Cdc20 or Cdh1, were transfected into 293T cells. After 24 h, cells were treated with
25mM MG132 for 7 h. Cell extracts were immunoprecipitated with an anti-HA antibody, and blotted with an anti-FLAG antibody and an anti-HA antibody.
IP, immunoprecipitation; MW, molecular weight in kDa; WCE, whole cell extracts. (e) The half-life of IVT-myc-tagged geminin proteins (WT, T25A and
T25D) was examined by the in vitro degradation assay. Cell extracts were obtained from synchronized HeLa cells in M (at mitotic shake-off). Cell lysates
were incubated with IVT-myc-tagged geminin protein for the indicated times. IVT-myc-tagged geminin protein expression was examined by
immunoblotting with an anti-myc antibody. (f) An in vitro ubiquitylation assay was performed using 35S-labelled IVT-geminin WT, gemininT25A or
gemininT25D, and immunopuriﬁed APC/CCdc20 from HeLa cells. 35S-labelled IVT-geminin proteins were incubated for the indicated times at 30 C.
The abundance of these proteins was detected by autoradiography. MW, molecular weight in kDa.
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gemininT25D, protein levels (Supplementary Fig. S2d). Moreover,
the in vitro ubiquitylation of gemininT25D via APC/CCdh1 was not
detectable, whereas that of wild-type geminin and gemininT25A
was observed (Fig. 2c). Interestingly, immunoprecipitation
analysis revealed that HA-tagged Cdh1 interacted with
wild-type geminin and gemininT25A, but not with gemininT25D
(Fig. 2d), indicating that the inability of gemininT25D to interact
with APC/CCdh1 may explain its resistance to APC/CCdh1-
dependent proteolysis.
GemininT25A protein levels were lower than wild-type geminin
protein levels at prometaphase (Fig. 2a), whereas in vitro-
translated wild-type geminin, which was not phosphorylated
on Thr25, and gemininT25A were degraded in mitotic extracts
(Fig. 2e), suggesting that phosphorylated geminin is protected
from degradation via APC/CCdc20. As expected, the in vitro
ubiquitylation of gemininT25D via APC/CCdc20 was not
detectable (Fig. 2f). Moreover, HA-Cdc20 interacted with
wild-type geminin and gemininT25A, but not with gemininT25D
(Fig. 2d). Thus, phosphorylation of geminin on Thr25 also
protects it from APC/CCdc20-mediated proteolysis in mitosis.
Next, to elucidate the physiological role of geminin
phosphorylation on Thr25, we generated an antibody against
geminin phosphorylated on Thr25. The l-PPase treatment
almost completely eliminated the recognition of geminin in
mitotic extracts by this antibody (Supplementary Fig. S3a).
Moreover, this antibody recognized the wild-type geminin, but
not gemininT25A (Supplementary Fig. S3b). We then used this
antibody to probe for geminin phosphorylated on Thr25 at M
and G1 phase. Thr25 phosphorylation of endogenous geminin
was detectable exclusively in mitosis (Supplementary Fig. S3c).
Thr25 of geminin is phosphorylated by Aurora-A. To further
deepen the understanding of geminin phosphorylation, we
identiﬁed which kinase phosphorylates geminin on Thr25. We
found that amino acids 23–26 (RRTL) within the D-box (which
include Thr25) matched the consensus sequences (R-X-S/T-L/V)
for phosphorylation by Aurora-A, a known mitotic kinase
(Fig. 3a). The serine/threonine kinase Aurora-A is essential for
mitotic entry, centrosome duplication, spindle formation, chro-
mosome segregation and cytokinesis15. Geminin was co-localized
with Aurora-A through mitotic progression (Fig. 3b and
Supplementary Fig. S4a), but Aurora-A and phosphorylated
geminin disappeared together in the G1 (Supplementary Fig.
S4b). Interestingly, APC/CCdh1 targets Aurora-A for the
destruction at mitotic exit16.
We then investigated the direct interaction between geminin
and Aurora-A. FLAG-tagged geminin co-immunoprecipitated
with Xpress-tagged Aurora-A (Fig. 3c). Moreover, the
endogenous interaction between Aurora-A and geminin was
observed in mitosis, but not in interphase (Fig. 3d). Thus,
Aurora-A exhibited mitosis-speciﬁc interaction with geminin.
To determine the ability of Aurora-A to phosphorylate geminin,
we performed an in vitro kinase assay. Aurora-A strongly
phosphorylated puriﬁed wild-type glutathione S-transferase
(GST)–geminin, but not GST–gemininT25A (Fig. 3e). Moreover,
a kinase-dead mutant (K162R) of Aurora-A displayed
signiﬁcantly reduced ability to phosphorylate geminin at Thr25,
which further highlights the speciﬁcity of Aurora-A-mediated
geminin phosphorylation (Fig. 3f). In fact, geminin
phosphorylated on Thr25 co-localized with Aurora-A in mitotic
cells (Supplementary Fig. S4b). Moreover, the depletion
of Aurora-A impaired geminin phosphorylation (Fig. 3g). As
shown in Fig. 2e, wild-type geminin and gemininT25A were
degraded in mitotic extracts, whereas wild-type geminin but not
gemininT25A was stabilized in mitotic extracts after in vitro
phosphorylation by Aurora-A (Fig. 3h). Moreover, a shorter
half-life of geminin was observed in Noc-arrested cells
after Aurora-A depletion (Supplementary Fig. S5). Cdc20
depletion stabilized geminin in mitotic Aurora-A-depleted cells
(Supplementary Fig. S5), indicating that Aurora-A-mediated
geminin phosphorylation prevents geminin degradation by
APC/CCdc20 at prometaphase.
Phosphorylated geminin stabilizes Cdt1 in mitosis. We then
investigated the physiological role of geminin phosphorylation
during mitosis. A previous report indicated that the inhibition
of geminin synthesis during mitosis leads to impaired pre-RC
formation and DNA replication in the ensuing cell cycle, and that
geminin binds and protects Cdt1 from proteasome-dependent
degradation to ensure the accumulation of Cdt1 in G2 and M
(ref. 3). Similarly, Cdt1 was reported to be rapidly downregulated
after geminin was silenced in Drosophila cells17. As shown by
previous studies3,18, we conﬁrmed that Cdt1 was hyperphos-
phorylated in mitosis and did not bind to chromatin (Supple-
mentary Fig. S6). Moreover, dephosphorylation of Cdt1 coincided
with chromatin association (Supplementary Fig. S6). A previous
report revealed that the inhibition of CDK1 in mitosis induced an
increase in the chromatin-associated Cdt1 fraction to the expense
of the soluble Cdt1, and that geminin bound with Cdt1 interfered
with this binding to the chromatin3. These ﬁndings suggest that
Cdt1 recruitment to chromatin may be regulated by dephos-
phorylation in late M. Interestingly, geminin downregulation and
Cdt1 recruitment to chromatin occur simultaneously (Supple-
mentary Fig. S6). To understand the role of geminin in Cdt1
recruitment to chromatin, we examined whether mitotic
depletion of geminin affected Cdt1 recruitment to chromatin
(Fig. 4a). Consistent with that published before3, mitotic
depletion of geminin decreased the levels of both soluble and
chromatin-associated Cdt1 and impaired MCM6 loading
(Fig. 4b). Interestingly, mitotic depletion of Aurora-A induced a
similar decrease in the level of both soluble and chromatin-
associated Cdt1 (Fig. 4c). These ﬁndings suggest that geminin
phosphorylated by Aurora-A stabilizes soluble Cdt1, which, in
turn, is recruited to the chromatin. In contrast to what was
observed when geminin was depleted during interphase19, mitotic
depletion of geminin or Aurora-A did not induce the DNA
damage response, as shown by the lack of Chk2 phosphorylation
(Supplementary Fig. S7). Moreover, the protein level and kinase
activity of Aurora-A were not affected by the depletion of mitotic
geminin (data not shown), and the phosphorylation of geminin
on Thr25 did not affect its interaction with Cdt1 (Supplementary
Fig. S8a).
Next, we examined whether introducing ectopic gemininT25D
rescued the downregulation of soluble Cdt1 protein at M phase in
geminin- or Aurora-A-depleted cells. As we used siRNA targeting
the 30-untranslated region region to deplete geminin, exogenous
geminin expression was not affected by this siRNA
(Supplementary Fig. S8b). Interestingly, ectopic gemininT25D in
geminin- or Aurora-A-depleted cells induced a stabilization of
soluble Cdt1 in M (Fig. 4b,c). As expected, the loading of
Cdt1 and MCM in G1 was suppressed by ectopic gemininT25D
(Fig. 4b,c), indicating that phosphorylated geminin, which cannot
be degraded via APC/C, prevents Cdt1 from loading onto
chromatin during M. Indeed, ectopic Cdt1 rescued the
impairment of MCM loading in geminin- or Aurora-A-depleted
cells (Fig. 5a,b). Moreover, the depletion of geminin or Aurora-A
in mitosis suppressed 5-bromodeoxyuridine (BrdU) incorporat-
ion in the ensuing S phase (Supplementary Fig. S9a,b and
Fig. 5c,d), even though the kinetics of mitotic exit was not
affected, as shown by the phosphorylation of histone H3 on Ser10
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Figure 3 | Phosphorylation of geminin on Thr25 by Aurora-A kinase during mitosis. (a) Comparison of the amino acid sequences of human geminin from
22 to 27 with those of phosphorylation sites of other known Aurora-A substrates. (b) Subcellular co-localization of geminin and Aurora-A during mitosis.
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mitotic cells (at mitotic shake-off) and adherent cells after mitotic shake-off. Cell lysates were immunoprecipitated with an anti-geminin polyclonal
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Expression of IVT-myc-tagged geminin protein was examined by immunoblotting with an anti-myc antibody. MW, molecular weight in kDa.
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(Figs 4b,c and 5a,b) and ﬂuorescence-activated cell sorting
analysis (Supplementary Figs S10 and S11). Ectopic
gemininT25D in geminin- or Aurora-A-depleted cells could not
rescue BrdU incorporation in the ensuing S phase
(Supplementary Fig. S9a,b). This is likely due to the
impairment of Cdt1 and MCM6 loading (Fig. 4b,c).
Interestingly, ectopic Cdt1 in geminin- or Aurora-A-depleted
cells rescued BrdU incorporation in the ensuing S phase
(Fig. 5c,d). These ﬁndings suggest that strict regulation of
geminin and Cdt1 protein levels depending on the cell cycle
phase may be essential for DNA replication.
Phosphorylated geminin interferes with Cdt1 degradation.
We investigated why soluble Cdt1 protein becomes unstable
when geminin is depleted in mitosis. Treatment with MG132 or
the neddylation inhibitor MLN4924 increased the soluble Cdt1
levels in mitotic geminin- or Aurora-A-depleted cells (Fig. 6a,b),
suggesting that soluble Cdt1 downregulation in response to the
mitotic depletion of geminin or Aurora-A may be caused by
ubiquitin-dependent proteolysis. During S and G2, human Cdt1
is recognized for proteolysis by two distinct E3 ubiquitin ligases,
SCFSkp2 and CRL4Cdt2 (ref. 20). It has been demonstrated that
Cdt1 is degraded via CRL4Cdt2 in geminin-depleted cells because
of the DNA damage response21. We also found that geminin
depletion induced Thr68 phosphorylation of Chk2, which is
phosphorylated by ataxia telangiectasia mutated (ATM)/ATM
and Rad3-related (ATR) after DNA damage (Supplementary
Fig. S7). However, geminin depletion in mitosis did not induce
DNA damage (Supplementary Fig. S7). These ﬁndings suggest
that Cdt1 may not be ubiquitylated by CRL4Cdt2 in mitotic
geminin-depleted cells. Indeed, Skp2 depletion, but not Cdt2
depletion, remarkably increased the soluble Cdt1 protein levels
(Fig. 6c). Accordingly, Skp2 depletion rescued the levels of both
soluble and chromatin-associated Cdt1 due to the mitotic
depletion of geminin or Aurora-A (Fig. 7a and b). In mitotic
geminin-depleted cells, Cdt1 expression was increased by the
introduction of ectopic FLAG-geminin in an amount-dependent
manner (Fig. 7c). SCFSkp2-dependent in vitro ubiquitylation of
Cdt1 was inhibited by adding in vitro-translated geminin protein
(Fig. 7d). Cdt1T29A, in the presence of which CDK
phosphorylation and Skp2 binding are impaired22, was not
ubiquitylated by SCFSkp2 (Fig. 7d). These ﬁndings indicate that in
mitosis, geminin may protect soluble Cdt1 from SCFSkp2-
dependent degradation for pre-RC formation.
Discussion
In this study, we describe a novel regulation of geminin during
mitosis (Fig. 7e and Supplementary Fig. S12). Aurora-A
phosphorylates geminin on Thr25 for it from protecting APC/
C-dependent proteolysis. Importantly, stabilized mitotic geminin
ensures pre-RC formation by protecting Cdt1 from SCFSkp2-
dependent proteolysis. The pre-RC formation regulated by the
Aurora-A–geminin–Cdt1 axis leads to proper DNA replication.
The APC/C complex distinctively targets speciﬁc substrates
and it is tightly regulated to adjust the critical timing of substrate
destruction7. However, it is still unclear how activated APC/C
speciﬁcally degrades each of a large number of substrates. In fact,
all its substrates are not necessarily degraded simultaneously by
APC/C, even though APC/C becomes active during mitosis. The
timing of the ubiquitylation of the substrates is tightly regulated
by the following mechanisms: (i) protein modiﬁcation, such as
phosphorylation or acetylation, protects the substrates from APC/
C16,23–26; (ii) intrinsic regulation of APC/C by substrate ordering
inﬂuences kinetic differences in the process of ubiquitylation27;
and (iii) the binding of proteins with APC/C substrates inhibits
ubiquitylation28. Phosphorylation protects Cdc6, Aurora-A,
Skp2 and geminin from APC/C-mediated degradation16,23–25.
In particular, the inability of phosphorylated Cdc6, Skp2 or
geminin to interact with APC/C explains its resistance to APC/C-
mediated proteolysis23,25. Recently, we demonstrated that the
phosphorylation of human Aurora-A on Ser51 inhibits its
APCCdh1-mediated ubiquitylation, and that constitutive
phosphorylation on Ser51 is observed in cancer cells with
protein overexpression and stabilization16. As geminin is highly
expressed in certain human cancers29,30, it will be interesting to
examine the involvement of geminin phosphorylation on Thr25
in cancer.
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Geminin restricts nuclear DNA replication to one round per
cell cycle, which ensures genome stability and prevents cells from
becoming aneuploid1. Re-replication may occur when the
pathways controlling pre-RC formation are impaired. Indeed,
geminin depletion in mammalian cells is sufﬁcient to cause
re-replication19,31, indicating that geminin has a critical role in
replication control. The pre-RC assembly reaction, known as
licensing, involves the loading of the Mcm2-7 complex in an
ATP-dependent reaction that requires ORC and two essential
factors, Cdc6 and Cdt1 (ref. 1). It is suggested that the binding of
geminin to Cdt1 protects the latter from ubiquitylation and
subsequent proteolysis3. In this study, we found that introduction
of in vitro-translated gemininT25D protein suppressed SCFSkp2-
dependent Cdt1 ubiquitylation (Fig. 7d), suggesting that geminin
protects soluble Cdt1 from SCFSkp2-dependent proteolysis by
interfering with the binding between Cdt1 and Skp2. However, as
Cdt2 depletion slightly increased soluble Cdt1 protein levels
(Fig. 6c), the possibility of Cdt1 degradation by CRL4Cdt2 in
mitotic geminin-depleted cells cannot be denied. Further detailed
studies on the mechanism of inhibition of Cdt1 ubiquitylation
may be required.
In Xenopus eggs, geminin is suggested to inhibit licensing from
S phase to metaphase and seems to be inactivated in interphase
through activation of the licensing process8,32–34. However, a
signiﬁcant proportion of molecules seems to escape degradation
at the metaphase–anaphase transition in Xenopus egg extracts35,
and the Cdt1-inhibiting activity of these remaining molecules
must be suppressed through mechanisms other than by
proteolysis. Indeed, exogenous geminin associates with and
inhibits Cdt1 in the interphase egg extracts4,8,35. Although
geminin rapidly disappears at the exit of mitosis and
accumulates during S phase in cultured cells2,4, the remaining
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Figure 7 | Geminin or Aurora-A depletion during mitosis induces SCFSkp2-dependent proteolysis of soluble Cdt1 protein. (a) Geminin depletion during
mitosis impaired licensing at mitotic exit. U2OS cells were treated with geminin and/or Skp2 siRNA during release from the second thymidine block
and collected at 0 and 2 h after release from the Noc block as described in Fig. 4a. The soluble and chromatin fractions were separated and immunoblotted
for the indicated proteins. MW, molecular weight in kDa; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; pHH, phospho-histone H3 (pHH3).
(b) Aurora-A depletion during mitosis impaired licensing at mitotic exit. U2OS cells were treated with Aurora-A and/or Skp2 siRNA during release from the
second thymidine block and collected at 0 and 2 h after release from the Noc block. Soluble and chromatin fractions were separated and immunoblotted for
the indicated proteins. (c) Cells were treated with the geminin siRNA during release from second thymidine block and collected immediately after mitotic
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Skp2 and Cul1 expression was examined by immunoblotting. (d) An in vitro ubiquitylation assay was performed using wild-type (WT) or T29A mutant
IVT-HA-tagged Cdt1 and immunopuriﬁed SCFSkp2 from 293T cells. WT IVT-HA-tagged Cdt1 protein was incubated with or without IVT-myc-tagged
gemininT25D protein for the indicated times. As a negative control, IVT-HA-tagged Cdt1T29A protein known as a non-degradable mutant for SCFSkp2-
mediated degradation was also used. The abundance of IVT-HA-tagged Cdt1 was detected by SDS–PAGE with a HA antibody. (e) Schematic model for
pre-RC formation regulated by the Aurora-A–geminin–Cdt1 axis. Aurora-A protects geminin from APC/CCdc20- and APC/CCdh1-mediated proteolysis
through phosphorylation. Phosphorylated geminin may stabilize soluble Cdt1 protein by inhibiting SCFSkp2-mediated proteolysis. Stabilized soluble Cdt1
may load onto chromatin after dephosphorylation and then form the pre-RC. MW, molecular weight in kDa.
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pool of geminin in the egg extracts may be regulated by Aurora-
A-mediated phosphorylation through escape from APC/C-
mediated degradation. It is interesting to examine the precise
molecular mechanism of this phenomenon in Xenopus eggs.
In S phase, chromatin-associated geminin presents even in the
absence of Cdt1, possibly as a precaution to prevent Cdt1 from
gaining access to chromatin if it accidentally accumulates during
S phase36. In this situation, geminin is phosphorylated at Ser45
and Ser49 in HeLa cells37, although the physiological relevance of
this modiﬁcation remains to be clariﬁed. Indeed, we identiﬁed
geminin phosphorylation on Thr25 by Aurora-A kinase during
mitosis. In Fig. 1c, the band of gemininT25D was still shifted at
G1 similar to that of wild-type geminin and other geminin
mutants (gemininS32D and gemininS60D), suggesting that geminin
is phosphorylated at multiple sites during mitosis. These ﬁndings
indicate that phosphorylation may be important for the
functional regulation of geminin in mammalian cells. Further-
more, we found that abundant soluble geminin and Cdt1 protein
expression was observed at prometaphase, and that abundant
chromatin-associated Cdt1 expression was observed during the
G1 phase. Although it is still unclear how the molecular
interaction between Cdt1 and geminin can be regulated during
M to G1 in mammalian cells, recent studies revealed that (i) the
geminin–Cdt1 complex can exist in two distinct forms, a
licensing-permissive heterotrimer and a licensing-inhibitory
heterohexamer, to regulate a molecular switch between
licensing-competent and licensing-defective states in Xenopus
and mammalian cells38 and (ii) the two forms of the Cdt1–
geminin complex act as active or inactive complexes for licensing
in Xenopus egg extracts39. In addition, geminin-mediated nuclear
Cdt1 foci formation supports the presence of local interactions
between geminin–Cdt1 complexes on chromatin in Xenopus egg
extracts40. Ode et al.40 suggested that the higher-order
interactions of Cdt1–geminin complexes are cooperatively
stabilized on chromatin. Overall, these ﬁndings suggest that
licensing for proper DNA replication may be strictly regulated
by the geminin protein level during cell cycle progression. The
amount of geminin, which is determined by Emi1- and Aurora-
A-mediated protection from APC/C-mediated proteolysis, may
thus be essential for proper DNA replication.
Methods
Reagents and antibodies. Reagents were from the following suppliers: MG132
(Z-Leu-Leu-Leu-CHO) (Peptide Institute Inc., Osaka, Japan); CHX (Sigma);
l-PPase (New England Bio Labs); MLN4924 (Millennium Pharmaceuticals).
The geminin phospho-Thr25-speciﬁc antibody was generated by immunizing
rabbits with the synthetic peptide CVPRR*TLKMIQ, corresponding to amino acids
21–30 of the human geminin sequence, with a phospho-threonine at position
25 (*T). The antibody was puriﬁed from serum by two rounds of afﬁnity chro-
matography, on a phospho-Thr25 peptide column and on a non-phosphopeptide
column. The anti-geminin polyclonal antibody was generated using GST fusion
recombinant molecules41, and the anti-Cdt1 monoclonal antibody was a gift from
Dr Kristian Helin (University of Copenhagen). Commercial antibodies were from
the following suppliers: anti-p27, anti-Aurora-A and anti-Aurora-B antibodies
(Transduction Laboratories); anti-HA (Y-11), anti-cyclin A, anti-cyclin B,
anti-MCM6, anti-Cdc25A, anti-Cdc6 and anti-GAPDH antibodies (Santa-Cruz
Biotechnology); anti-phospho-Histone H3 (Ser10) antibody (Upstate); anti-Cul1,
anti-Emi1, anti-Skp2 and anti-PLK1 antibodies (Zymed); anti-Xpress antibody
(Invitrogen); anti-Cdh1 antibody (MBL); anti-geminin (2H7) antibody (Abnova);
anti-histone H2A antibody (Abcam); anti-FLAG (M2) and anti-b-actin antibodies
(Sigma); anti-phospho-tyrosine antibody (Merck Millipore); anti-Cdt1 and anti-
Cdt2 antibodies (Bethyl).
Plasmids. pEF-FLAG-tagged geminin and pcDNA-HA-tagged Cdt1 were kind
gifts from Dr Anindya Dutta (University of Virginia). To produce GST-tagged
recombinant proteins, geminin complementary DNA was subcloned into pGEX
4T-1 vectors (GE Healthcare). For in vitro translation, geminin cDNA was also
subcloned into pcDNA3.1 His/myc-tagged vectors (Invitrogen). The pcDNA3.1
His/Xpress-tagged Aurora-A was previously described16. pCMV HA-tagged Cdt1
and HA-tagged Cdh1 expression vectors were gifts from Dr Kristian Helin
(University of Copenhagen). The pEF, pGEX and pcDNA3.1 vectors encoding the
FLAG-tagged geminin substitution mutants (T25A and T25D), the pcDNA3.1
vector encoding His/Xpress-tagged Aurora-A kinase-dead mutant (K162R) and
the pcDNA3 vector encoding HA-tagged Cdt1 substitution mutant (T29A)
were generated using a KOD plus mutagenesis kit (Toyobo).
Cell culture and transient transfection. HeLa, U2OS and 293T cells were
routinely maintained in DMEM (Nissui Pharmaceutical Co. Ltd, Tokyo, Japan)
supplemented with 10% heat-inactivated fetal bovine serum (Gibco) and
100Uml 1 penicillin–streptomycin (Gibco) at 37 C and 5% CO2 in air.
For experiments, cells were grown to subconﬂuence in this medium. Transient
transfections were performed using FuGENE HD (Roche) following the manu-
facturer’s instructions. For synchronization, Noc (Sigma) and thymidine (Sigma)
were used. HeLa cells were synchronized at prometaphase using 50 ngml 1
Noc treatment followed by mitotic shake-off. Subsequently, synchronized cells were
released from the mitotic arrest by washing out Noc. Adherent cells remaining after
mitotic shake-off were also used. Adherent cells dominantly included the cells
arrested at G2, as conﬁrmed by FACS analysis (data not shown). U2OS were
synchronized at the G1/S border by a double thymidine block. In brief, cells were
incubated for 20 h in 2mM thymidine (Sigma), released for 8 h and then incubated
for another 20 h in 2mM thymidine.
Immunoprecipitation and immunoblot analysis. Cells were transfected with
vectors by using FuGENE HD (Roche). Cell lysis and immunoprecipitation
were performed as described13. Twenty micrograms of protein were subjected to
10% PAGE followed by electroblotting onto a nitrocellulose membrane. To detect
the immunocomplex, an ECL Western blotting detection system (Amersham) was
used. The immunoprecipitates were subjected to immunoblot analysis. To detect
phospho-Thr25 geminin, we performed immunoprecipitation with a phospho-
speciﬁc antibody against Thr25 of geminin, followed by immunoblotting analysis
with a monoclonal antibody against endogenous geminin or an anti-FLAG
antibody against FLAG-tagged exogenous geminin.
In vitro ubiquitylation assay. Ubiquitylation assays were performed as previously
described16. [35S]methionine-labelled human geminin protein was prepared by
coupled transcription–translation reactions in wheat germ extract (Promega).
GST-tagged Cdh1 (Abnova) or cold in vitro-translated human Cdc20 protein was
also used. The extracts from HeLa cells were immunoprecipitated with an anti-
Cdc27 antibody (Sigma). Immunoprecipitants were incubated with Cdh1 or Cdc20
for 1 h at 37 C and washed four times in QA buffer (10mM Tris–HCl pH 7.5,
100mM KCl, 1mM MgCl2, 0.1mM CaCl2, 1mM dithiothreitol (DTT)). The
puriﬁed APC/CCdh1 or APC/CCdc20 complexes were incubated in reaction mixtures
containing the following components in a volume of 7 ml: 40mM Tris–HCl
(pH 7.6), 1mgml 1 carboxymethyl BSA, 1mM DTT, 5mM MgCl2, 10mM
phosphocreatine, 50 mgml 1 creatine phosphokinase, 0.5mM ATP, 50 mM
ubiquitin, 1 mM ubiquitin aldehyde, 1 pmol of E1, 5 pmol of E2-C, 1 mM okadaic
acid and 1–2 pmol of [35S]methionine-labelled human geminin protein.
Following incubation at 30 C for 2 h, samples were loaded for electrophoresis
on an 8% polyacrylamide–SDS gel.
In vitro ubiquitylation assays for Cdt1 were performed in a volume of
30 ml containing 0.1 mM E1 (Boston Biochem), 10 ngml 1 Ubch3, 10 ngml 1
Ubch5c, 1 mM ubiquitin aldehyde, 2.5 mgml 1 ubiquitin (Sigma) and SCFSkp2
complex in a ubiquitylation buffer (50mM Tris (pH 7.6), 2mM ATP, 5mMMgCl2,
0.6mM DTT, 0.1 mM okadaic acid). In vitro-translated HA-tagged wild-type Cdt1
or Cdt1T29A was used as the substrate. The reactions were incubated at 30 C for
the indicated times and analysed by SDS–PAGE with an anti-HA antibody. The
SCFSkp2 complex was obtained from the lysates of 293T cells after transfection with
FLAG-tagged Skp2 together with other SCF components. After 24 h of transfection,
cells were incubated with MG132 for 3 h before lysis. Anti-FLAG antibody was
used to immunoprecipitate the SCFSkp2 complex. The immunoprecipitants were
washed four times in lysis buffer and two times in ubiquitylation reaction buffer
(10mM Tris–HCl pH 7.5, 100mM NaCl, 5mM MgCl2 and 1mM DTT). Finally,
beads were then used for in vitro ubiquitylation assays.
Chromatin fractionation. For chromatin fractionation, we separated the soluble
and insoluble fractions as previously described42. Brieﬂy, cells were lysed in
CSK buffer and centrifuged for 4min at 3,200 r.p.m. After centrifugation, the
supernatant contained the soluble fraction. The pellet was resuspended in
2 Laemmli buffer after washing with CSK buffer and then sonicated.
This lysate contained the chromatin-enriched fraction.
RNA interference. The following siRNA oligonucleotides were obtained from
Qiagen: geminin, 50-CCUAUUGCAUUAAAGUACA-30 ; Aurora-A, 50-CACCUU
CGGCAUCCUAAUA-30 ; and Cdh1, 50-UCUGGUGGACUGGUCGUCC-30 .
Emi1 siRNA was obtained from Dhamacon as the following sequence: 50-GAUUG
UGAUCUCUUAUUAA-30 . Cdt2 siRNA was obtained from Bonac (Kurume,
Japan) as the following sequence: 50-CAAUGGACACCAGAACUCUACCUUU-30 .
The negative control (siTrio-negative control siRNA) was obtained from Cosmo
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Bio Inc. (Tokyo, Japan). Transfections were performed using 20 nM siRNA and
Oligofectamine RNAi MAX (Invitrogen), according to the manufacturer’s
instructions.
In vitro degradation assay. For M or G1 extracts, HeLa cells were synchronized in
prometaphase by Noc treatment and collected at 0 or 5 h after mitotic shake-off.
The collected cells were lysed in hypotonic buffer (25mM HEPES pH 7.5, 1.5mM
MgCl2, 5mM KCl, 1mM DTT, 15mM creatine phosphate, 2mM ATP) by ten
freeze-and-thaw cycles and centrifuged for 5min at 5,000 r.p.m. and subsequently
for 60min at 13,200 r.p.m. As a substrate, cold IVT-myc-geminin (wild-type, T25A
and T25D) was prepared by coupled transcription–translation reactions in wheat
germ extracts (Promega). The substrate was incubated in 20 ml of cell extract and a
degradation cocktail containing the following components in a volume of 20 ml:
1.5mgml 1 ubiquitin, 7.5mM creatine phosphate, 1mM ATP, 1mM MgCl2 and
25mgml 1 CHX. Following incubation at 30 C for 2, 4 and 6 h, samples were
loaded for electrophoresis on a 12% polyacrylamide–SDS gel.
Immunoﬂuorescence. Cells were grown on glass coverslips, ﬁxed in 4% paraf-
ormaldehyde for 10min and permeabilized with PBS containing 0.1% Triton X-100
for 20min. After three rinses with PBS, the coverslips were incubated with the
primary antibodies. Anti-geminin, anti-geminin phospho-Thr25 and anti-Aurora-
A antibodies were used. Alexa Fluor 488-conjugated anti-mouse or rabbit IgG and
Alexa Fluor 594-conjugated anti-mouse or rabbit IgG were used as secondary
antibodies (Invitrogen). DNA was visualized by DAPI (40 ,6-diamidino-2-pheny-
lindole) staining. Immunostaining of the cell preparations was recorded by using
an epiﬂuorescence Zeiss Axioplan 2 microscope (Zeiss, Inc., Thornwood, NY)
attached to a charge-coupled-device camera.
In vitro kinase assay. GST-tagged wild-type and gemininT25A mutant geminin
were subcloned into pGEX, expressed in E. coli and puriﬁed. Aurora-A kinase was
obtained from Millipore. Puriﬁed GST-tagged wild-type geminin or gemininT25A
was incubated with Aurora-A in a kinase reaction buffer (25mM Tris–HCl pH 7.5,
5mM b-glycerophosphate, 2mM DTT, 0.1mM Na3VO4, 10mM MgCl2 and
0.1mM ATP) supplemented with 5 mCi of [g-32P] ATP at 30 C for 60min. The
reactions were stopped with Laemmli buffer for 5min at 95 C. After the reaction
mixtures were resolved by SDS–PAGE, the gels were stained with Coomassie
brilliant blue, and were dried and subjected to autoradiography.
BrdU staining. Cells were treated with 33mM BrdU for 30min at 10.5 h after
double thymidine block release (Fig. 4a). Cells were then ﬁxed with 70% ethanol
containing 10mM glycine for 10min, stained with mouse anti-BrdU primary
antibody (Roche) and ﬂuorescein-conjugated anti-mouse IgG secondary antibody
(Roche), and analysed by indirect immunoﬂuorescence. Nuclei were simulta-
neously counterstained with DAPI. The BrdU-positive nuclei were counted and
plotted. Three independent counts (n¼ 150 cells each count) were used to calculate
mean±s.d.
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